June 8, 2017 -- Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is seeking remo
DUBLIN--(BUSINESS WIRE)--Jun. 6, 2017-- Alkermes plc (NASDAQ: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved two-month Aristada (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizo
FRIDAY, June 2, 2017 -- For people who battled cancer in childhood, the prospects for a long life without cancer recurrence or chronic illness are better than ever, a new study finds.Thats largely due to changes in cancer treatment protocols that have
FRIDAY, June 2, 2017 -- Medication can help millions of people who struggle with depression, according to the U.S. Food and Drug Administration.Depression affects some 350 million people worldwide. Its a serious illness and a major cause of disability
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:Heart Pump Controllers RecalledNearly 29,000 controllers for implanted heart pumps are being recalled after reports of malfunctions resulting in
FDA Approves KevzaraSanofi and Regeneron Announce FDA Approval of Kevzara (sarilumab) for Rheumatoid Arthritis PARIS and TARRYTOWN, N.Y., May 22, 2017 /PRNewswire/ -- Sanofi and Regeneron Pharmaceuticals, Inc. today announced the U.S. Food and Dr